MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$230,206
-37.7%
14,352
-9.9%
0.00%
-25.0%
Q2 2023$369,234
-4.7%
15,929
-4.5%
0.00%
-20.0%
Q1 2023$387,639
+57.3%
16,687
-1.7%
0.01%
+66.7%
Q4 2022$246,423
-19.5%
16,983
+5.9%
0.00%
-25.0%
Q3 2022$306,000
+24.9%
16,043
+18.9%
0.00%
+33.3%
Q2 2022$245,000
-15.5%
13,494
+17.3%
0.00%0.0%
Q1 2022$290,000
-3.7%
11,507
+5.5%
0.00%0.0%
Q4 2021$301,000
-10.4%
10,910
+4.8%
0.00%0.0%
Q3 2021$336,000
+0.3%
10,409
-5.0%
0.00%0.0%
Q2 2021$335,000
+9.5%
10,954
+9.1%
0.00%0.0%
Q1 2021$306,000
+64.5%
10,044
+6.9%
0.00%
+50.0%
Q4 2020$186,000
+59.0%
9,397
+4.4%
0.00%0.0%
Q3 2020$117,000
+185.4%
9,005
+149.5%
0.00%
+100.0%
Q2 2020$41,000
-12.8%
3,609
+10.2%
0.00%0.0%
Q1 2020$47,000
-34.7%
3,275
+24.1%
0.00%0.0%
Q4 2019$72,000
-10.0%
2,639
-5.0%
0.00%0.0%
Q3 2019$80,000
+9.6%
2,778
+5.8%
0.00%0.0%
Q2 2019$73,000
+4.3%
2,626
+25.2%
0.00%0.0%
Q1 2019$70,000
+32.1%
2,097
+15.0%
0.00%0.0%
Q4 2018$53,000
-14.5%
1,824
+35.2%
0.00%0.0%
Q3 2018$62,000
+520.0%
1,349
+424.9%
0.00%
Q2 2018$10,0002570.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 5,809,799$205,667,0004.45%
Tieton Capital Management, LLC 146,650$5,191,0003.90%
KESTREL INVESTMENT MANAGEMENT CORP 614,275$21,745,0002.97%
Provident Investment Management, Inc. 375,032$13,276,0002.70%
Summit Street Capital Management, LLC 77,810$2,754,0002.46%
RATIONAL ADVISORS LLC 253,200$8,963,0002.17%
S&T BANK/PA 393,446$13,928,0002.08%
Euclidean Technologies Management, LLC 63,684$2,254,0002.05%
Grace Capital 220,769$7,815,0001.76%
AIMZ Investment Advisors, LLC 57,850$2,048,0001.75%
View complete list of MYRIAD GENETICS INC shareholders